• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4836766)   Today's Articles (8156)
For: Desnoyers A, Wilson BE, Nadler MB, Amir E. Fragility index of trials supporting approval of anti-cancer drugs in common solid tumours. Cancer Treat Rev 2021;94:102167. [PMID: 33652263 DOI: 10.1016/j.ctrv.2021.102167] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2020] [Revised: 02/01/2021] [Accepted: 02/03/2021] [Indexed: 01/04/2023]
Number Cited by Other Article(s)
1
Bi Y, Wei H, Ma Q, Wang R, Jin J, Qu K, Liu Y, Zhai Z, Zhu L, Wang J. The fragility index of randomized controlled trials in advanced/metastatic renal cell cancer. Urol Oncol 2025;43:333.e9-333.e15. [PMID: 40155257 DOI: 10.1016/j.urolonc.2025.03.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2024] [Revised: 02/06/2025] [Accepted: 03/02/2025] [Indexed: 04/01/2025]
2
Braik D, Lemieux C, Wilson BE, Salawu A, Abdul Razak AR. Clinical benefit and fragility evaluation of systemic therapy trials for advanced soft tissue sarcoma. Cancer 2025;131:e35564. [PMID: 39292680 DOI: 10.1002/cncr.35564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2024] [Revised: 08/14/2024] [Accepted: 08/15/2024] [Indexed: 09/20/2024]
3
Olsen HE, Kao PC, Richmond C, Shulman DS, London WB, DuBois SG. Statistical Fragility of Findings From Randomized Phase 3 Trials in Pediatric Oncology. Cancer Med 2024;13:e70356. [PMID: 39676273 DOI: 10.1002/cam4.70356] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2024] [Revised: 08/28/2024] [Accepted: 10/11/2024] [Indexed: 12/17/2024]  Open
4
Nanji K, Xie J, Hatamnejad A, Pur DR, Phillips M, Zeraatkar D, Wong TY, Guymer RH, Kaiser PK, Sivaprasad S, Bhandari M, Steel DH, Wykoff CC, Chaudhary V. Exploring the fragility of meta-analyses in ophthalmology: a systematic review. Eye (Lond) 2024;38:3153-3160. [PMID: 39033242 PMCID: PMC11543934 DOI: 10.1038/s41433-024-03255-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2024] [Revised: 06/13/2024] [Accepted: 07/15/2024] [Indexed: 07/23/2024]  Open
5
Luo M, Huang J, Wang Y, Li Y, Liu Z, Liu M, Tao Y, Cao R, Chai Q, Liu J, Fei Y. How fragile the positive results of Chinese herbal medicine randomized controlled trials on irritable bowel syndrome are? BMC Complement Med Ther 2024;24:300. [PMID: 39143474 PMCID: PMC11323352 DOI: 10.1186/s12906-024-04561-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2024] [Accepted: 06/21/2024] [Indexed: 08/16/2024]  Open
6
Proal JD, Moon AS, Kwon B. The fragility index and reverse fragility index of FDA investigational device exemption trials in spinal fusion surgery: a systematic review. EUROPEAN SPINE JOURNAL : OFFICIAL PUBLICATION OF THE EUROPEAN SPINE SOCIETY, THE EUROPEAN SPINAL DEFORMITY SOCIETY, AND THE EUROPEAN SECTION OF THE CERVICAL SPINE RESEARCH SOCIETY 2024;33:2594-2603. [PMID: 38802596 DOI: 10.1007/s00586-024-08317-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/09/2024] [Revised: 04/20/2024] [Accepted: 05/16/2024] [Indexed: 05/29/2024]
7
McKechnie T, Brennan K, Eskicioglu C, Farooq A, Patel SV. Applying the fragility index to randomized controlled trials evaluating total neoadjuvant therapy for rectal cancer: A methodological survey. Radiother Oncol 2024;194:110148. [PMID: 38341094 DOI: 10.1016/j.radonc.2024.110148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2023] [Revised: 01/08/2024] [Accepted: 02/05/2024] [Indexed: 02/12/2024]
8
Tang M, Pearson SA, Simes RJ, Chua BH. Harnessing Real-World Evidence to Advance Cancer Research. Curr Oncol 2023;30:1844-1859. [PMID: 36826104 PMCID: PMC9955401 DOI: 10.3390/curroncol30020143] [Citation(s) in RCA: 40] [Impact Index Per Article: 20.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2022] [Revised: 01/16/2023] [Accepted: 01/30/2023] [Indexed: 02/05/2023]  Open
9
Huang H, Tang Y, Yu Y, Yu A, Wu D, Fang H, Wang S, Sun C, Wang X, Fan Q, Fang Y, Tang Q, Jiang N, Du J, Miao H, Bai Y, Ma P, Xing S, Cui D, Miao S, Jiang Y, Zhu J, Zhu Q, Leng Y, Guo LW, Liao S, Shao Y, Song Y, Liu Z, Hong M, Luo S, Xu B, Lan G, Li N. The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challenges. THE LANCET REGIONAL HEALTH. WESTERN PACIFIC 2023;31:100624. [PMID: 36426285 PMCID: PMC9678947 DOI: 10.1016/j.lanwpc.2022.100624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/01/2022] [Revised: 09/20/2022] [Accepted: 10/13/2022] [Indexed: 11/19/2022]
10
Liu Q, Chen H, Gao Y, Zhu C. Robustness of Significant Dichotomous Outcomes in Randomized Controlled Trials in the Treatment of Patients with COVID-19: A Systematic Analysis. INTENSIVE CARE RESEARCH 2023;3:38-49. [PMID: 36687387 PMCID: PMC9836340 DOI: 10.1007/s44231-022-00027-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Accepted: 12/23/2022] [Indexed: 01/13/2023]
11
Fragility indices for only sufficiently likely modifications. Proc Natl Acad Sci U S A 2021;118:2105254118. [PMID: 34848537 DOI: 10.1073/pnas.2105254118] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/13/2021] [Indexed: 11/18/2022]  Open
12
The fragility index in 2010-2021 chronic lymphocytic leukemia randomized controlled trials. Blood Adv 2021;6:225-227. [PMID: 34753170 PMCID: PMC8753221 DOI: 10.1182/bloodadvances.2021006473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2021] [Accepted: 11/04/2021] [Indexed: 11/22/2022]  Open
13
Wilson BE, Desnoyers A, Nadler MB, Tibau A, Amir E. Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations. Cancer Med 2021;10:5405-5414. [PMID: 34323019 PMCID: PMC8366090 DOI: 10.1002/cam4.4029] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2021] [Revised: 04/21/2021] [Accepted: 04/23/2021] [Indexed: 12/11/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA